KDR and neoplasm: ENMD-2076, a small-molecule kinase inhibitor with activity against the Aurora kinases A and B and several other tyrosine kinases, including VEGFR-2, cKit, and FGFR1, inhibited tumor growth in murine xenograft models of human CRC [77].